• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 3 Device Recall BD Shigella poly Group D Antiserum S. sonnei

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 3 Device Recall BD Shigella poly Group D Antiserum S. sonnei see related information
Date Initiated by Firm January 25, 2010
Date Posted March 16, 2010
Recall Status1 Terminated 3 on May 21, 2010
Recall Number Z-1149-2010
Recall Event ID 54374
Product Classification Antigens, all groups, shigella spp. - Product Code LIA
Product BD Shigella poly Group D Antiserum S. sonnei; types I,II, packaged in 3 mL vials, Catalog #24103, and labeled in part. Becton, Dickinson and Company, 7 Loveton Circle, Sparks, MD 21152 USA.

Used to confirm the identification of isolates that are morphologically and biochemically identified as Shigella species.

Code Information Lot Number: 8032036, exp 7/23/2010 and Lot Number: 9110319, exp 11/17/2011. 
Recalling Firm/
Manufacturer
Becton Dickinson & Co.
7 Loveton Cir
Sparks MD 21152-9212
For Additional Information Contact
410-316-4000
Manufacturer Reason
for Recall
In vitro diagnostic test reagent may exhibit decreased reactivity.
FDA Determined
Cause 2
Nonconforming Material/Component
Action BD Diagnostic Systems issued an "Urgent Product Recall" notification dated January 2010. Consignees were advised to discontinue use of the affected product and discard for replacement or credit. For further information, contact BD Diagnostic Systems, Customer Service at 1-800-675-0908.
Quantity in Commerce 1096 units
Distribution Nationwide Distribution
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-